Biotech · Public company · Redwood City, CA, US

Coherus Oncology, Inc.

Ticker CHRS · SEC CIK 0001512762

Track this companyFree. Adds Coherus Oncology, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials2213 recruiting or active

Pipeline programs31From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availableNo recent cash burn filed

Pipeline31

AdalimumabPhase 3 · Plaque PsoriasisClinicalTrials.gov · fetched Nov 12, 2026
CHS-0214Phase 3 · Plaque PsoriasisClinicalTrials.gov · fetched Nov 12, 2026
CHS-0214Phase 3 · Rheumatoid ArthritisClinicalTrials.gov · fetched Nov 12, 2026
CHS-1420Phase 3 · Plaque PsoriasisClinicalTrials.gov · fetched Nov 12, 2026
EtanerceptPhase 3 · Plaque PsoriasisClinicalTrials.gov · fetched Nov 12, 2026
EtanerceptPhase 3 · Rheumatoid ArthritisClinicalTrials.gov · fetched Nov 12, 2026
AtezolizumabPhase 2 · Hepatocellular CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
BevacizumabPhase 2 · Hepatocellular CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
CasdozokitugPhase 2 · Hepatocellular CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
etrumadenantPhase 2 · Metastatic Castration-resistant Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
SRF617Phase 2 · Metastatic Castration-resistant Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
ToripalimabPhase 2 · Hepatocellular CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
zimberelimabPhase 2 · Metastatic Castration-resistant Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
5 FluorouracilPhase 1 · Metastatic Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
Albumin-Bound PaclitaxelPhase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
CHS-006 (anti-TIGIT)Phase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
CHS-114Phase 1 · Metastatic Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
CHS-114Phase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
CHS-388Phase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
CisplatinPhase 1 · Metastatic Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
GemcitabinePhase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
PembrolizumabPhase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
SRF617Phase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
toripalimabPhase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
ToripalimabPhase 1 · Metastatic Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
toripalimab (anti-PD-1)Phase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
CarboplatinNasopharyngeal Cancer RecurrentClinicalTrials.gov · fetched Nov 12, 2026
CisplatinNasopharyngeal Cancer RecurrentClinicalTrials.gov · fetched Nov 12, 2026
GemcitabineNasopharyngeal Cancer RecurrentClinicalTrials.gov · fetched Nov 12, 2026
Pegfilgrastim-CbqvFebrile NeutropeniaClinicalTrials.gov · fetched Nov 12, 2026
ToripalimabNasopharyngeal Cancer RecurrentClinicalTrials.gov · fetched Nov 12, 2026

Clinical trials22

PhII Study of Toripalimab Followed by Definitive CRT & Adjuvant Toripalimab in Locally Advanced ESCCPHASE2 · NOT_YET_RECRUITING · started Dec 31, 2026ClinicalTrials.gov NCT07836049 · fetched Nov 12, 2026
Neoadjuvant Dupilumab and Toripalimab in MSS CRC Subjects With Resectable Liver MetastasesPHASE1_PHASE2 · RECRUITING · started Sep 1, 2026ClinicalTrials.gov NCT07277322 · fetched Nov 12, 2026
Window of Opportunity in Preserving Laryngeal Function TrialPHASE2 · RECRUITING · started Apr 6, 2026ClinicalTrials.gov NCT07423078 · fetched Nov 12, 2026
PDT For Induction Therapy For Head And Neck CancerPHASE2 · RECRUITING · started Mar 9, 2026ClinicalTrials.gov NCT07214987 · fetched Nov 12, 2026
Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)PHASE2 · RECRUITING · started Feb 18, 2026ClinicalTrials.gov NCT07209189 · fetched Nov 12, 2026
Combination Immunotherapy for the Treatment of Chemotherapy-refractory Metastatic MSS CRCPHASE1_PHASE2 · RECRUITING · started Dec 1, 2025ClinicalTrials.gov NCT07281716 · fetched Nov 12, 2026
Immunotherapy (Toripalimab) for Reducing Recurrence Risk After Surgery for Mismatch Repair Deficient Stage IIB, IIC, or III Colon CancerPHASE2 · RECRUITING · started Sep 19, 2025ClinicalTrials.gov NCT07140679 · fetched Nov 12, 2026
Toripalimab With Chemotherapy for Sinus CancerPHASE2 · RECRUITING · started Jun 17, 2025ClinicalTrials.gov NCT06940180 · fetched Nov 12, 2026
STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected SarcomasPHASE1_PHASE2 · RECRUITING · started May 5, 2025ClinicalTrials.gov NCT06975293 · fetched Nov 12, 2026
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid TumorsPHASE1 · RECRUITING · started Apr 1, 2025ClinicalTrials.gov NCT06657144 · fetched Nov 12, 2026
A Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular CarcinomaPHASE2 · ACTIVE_NOT_RECRUITING · started Dec 20, 2024ClinicalTrials.gov NCT06679985 · fetched Nov 12, 2026
A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal CancerPHASE4 · RECRUITING · started Nov 1, 2024ClinicalTrials.gov NCT06457503 · fetched Nov 12, 2026
Study to Evaluate Safety and PK of CHS-006 in Combination With Toripalimab in Patients With Advanced Solid TumorsPHASE1 · TERMINATED · started Apr 26, 2023ClinicalTrials.gov NCT05757492 · fetched Nov 12, 2026
Study of CHS-114 in Participants With Advanced Solid TumorsPHASE1 · ACTIVE_NOT_RECRUITING · started Dec 15, 2022ClinicalTrials.gov NCT05635643 · fetched Nov 12, 2026
Trial of Atezolizumab and Bevacizumab With CHS-388 or Placebo in Patients With Hepatocellular CarcinomaPHASE2 · TERMINATED · started Apr 12, 2022ClinicalTrials.gov NCT05359861 · fetched Nov 12, 2026
Study of SRF617 With AB928 (Etrumadenant) and AB122 (Zimberelimab) in Patients With Metastatic Castration Resistant Prostate CancerPHASE2 · TERMINATED · started Jan 17, 2022ClinicalTrials.gov NCT05177770 · fetched Nov 12, 2026
An Analysis to Estimate Febrile Neutropenia (FN) in Patients Receiving UdenycaUNKNOWN · started Aug 1, 2020ClinicalTrials.gov NCT04662892 · fetched Nov 12, 2026
Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid TumorsPHASE1 · COMPLETED · started Apr 22, 2020ClinicalTrials.gov NCT04374877 · fetched Nov 12, 2026
Study of SRF617 in Patients With Advanced Solid TumorsPHASE1 · COMPLETED · started Mar 16, 2020ClinicalTrials.gov NCT04336098 · fetched Nov 12, 2026
Comparison of CHS-1420 Versus Humira in Subjects With Chronic Plaque PsoriasisPHASE3 · COMPLETED · started Aug 1, 2015ClinicalTrials.gov NCT02489227 · fetched Nov 12, 2026
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO)PHASE3 · COMPLETED · started Jun 16, 2014ClinicalTrials.gov NCT02134210 · fetched Nov 12, 2026
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)PHASE3 · COMPLETED · started May 1, 2014ClinicalTrials.gov NCT02115750 · fetched Nov 12, 2026

SEC filings12

10-Q · 10-QSEC EDGAR · filed Nov 9, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Nov 9, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Oct 29, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Aug 28, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Aug 17, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Aug 17, 2026 · fetched Nov 12, 2026
10-Q · 10-QSEC EDGAR · filed Aug 5, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Aug 5, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Jun 15, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Jun 1, 2026 · fetched Nov 12, 2026
10-Q · 10-QSEC EDGAR · filed May 11, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed May 11, 2026 · fetched Nov 12, 2026